000			04574cam a2200457Mi 4500
988			_aSpringer_Medicine_2017
999			_c96412 _d96412 _x1
001			96412
003			ES-MaUEC
005			20230102112752.0
006			m o d
007			cr cnu---unuuu
008			170812s2017 sz o 000 0 eng d
020			_a3319565826 _q(electronic bk.)
020			_a9783319565828 _q(electronic bk.)
020			_z3319565818
020			_z9783319565811
040			_aEBLCP _cEBLCP _dYDX _dN$T _dGW5XE _dAZU _dUPM _dOCLCQ _dOCLCO _dCOO _dUAB _dES-MaUEC _bspa
050		4	_aRC655 _b2017 EB
100	1		_aPiciu, Doina.
245	1	0	_aNuclear endocrinology _cDoina Piciu.
250			_a2nd ed.
264		1	_aCham _bSpringer _c2017.
300			_a1 recurso en línea (304 páginas)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
500			_a6.2.6.4 Technetium-99m (V) DMSA (Tc-99m (V) DMSA).
500			_aSpringerLink
505	0		_aPreface; Note; Contents; Contributors; Introduction; Further Reading; Part I: General Nuclear Medicine; 1: Principles of Nuclear Medicine; 1.1 Principles and History of Nuclear Medicine; 1.2 Basics of Nuclear Physics; 1.2.1 Atomic Structure; 1.2.2 Radioactivity; 1.2.2.1 Radioactive Decay: Alpha Decay (Eq. 1.1); 1.2.2.2 Radioactive Decay: Beta Decay (Eq. 1.3); 1.2.2.3 Radioactive Decay: Gamma Decay (Eq. 1.6); 1.2.2.4 Electron Capture; 1.2.2.5 Decay Equations; 1.2.3 Interaction of Radiation with Matter; 1.2.3.1 Photoelectric Effect; 1.2.3.2 Compton Effect; Further Reading.
505	8		_a2: Specific Measurements, Units, and TermsFurther Reading; 3: Dosimetry; 3.1 Decays of Radionuclides and Doses Calculation; 3.1.1 Fluorine F-18; 3.1.2 Gallium Ga-68 and Gallium Ga-67; 3.1.3 Radioiodine I-123; 3.1.4 Radioiodine I-124; 3.1.5 Radioiodine I-125; 3.1.6 Radioiodine I-131; 3.1.7 Indium In-111; 3.1.8 Lutetium Lu-177; 3.1.9 Techentium-99m (Tc-99m); 3.1.10 Thallium Tl-201; 3.1.11 Yttrium Y-90; 3.2 Dose Rates to Target and Critical Organ; Further Reading; 4: The Radiation Protection; 4.1 Basic Factors in Radiation Protection; 4.2 Staff Protection in Nuclear Medicine Units.
505	8		_a4.3 General Measures to Reduce the Irradiation of Patient4.4 Physical Factors in Radiation Protection; 4.4.1 Time; 4.4.2 Distance; 4.4.3 Shielding; 4.5 Special Recommendations for Patients Undergoing Nuclear Medicine Procedures; 4.5.1 For Female Patients of Childbearing Age and Breastfeeding; 4.5.2 Procedures in Case of Nuclear Events; 4.5.2.1 Actions for Person Decontamination; 4.5.2.2 Actions for Room Decontamination; Further Reading; 5: Equipments in Nuclear Medicine; 5.1 Gamma Camera; 5.1.1 Collimators; 5.1.2 Crystals; 5.1.3 The Photomultiplier Tubes.
505	8		_a5.1.4 Imaging and Processing5.2 Instruments for Thyroid Uptake Evaluation; 5.3 Positron Emission Tomography (PET) and Fusion Images Equipments (PET/CT); 5.4 Whole-Body Counting Systems; 5.5 Gamma Probe Equipment; Further Reading; 6: Radiopharmaceuticals; 6.1 Introduction; 6.2 Radiopharmaceuticals in Endocrinology; 6.2.1 Fluorine-18 Fluorodeoxyglucose (18F-FDG); 6.2.2 Fluorine-18 Fluorocholine (18F-FCH); 6.2.3 Radiopharmaceuticals with Gallium-68 and Gallium-67; 6.2.4 Radiopharmaceuticals with Radioiodine; 6.2.4.1 Radioiodine I-123 Sodium Iodide (I-123 NaI).
505	8		_a6.2.4.2 Radioiodine I-124 Sodium Iodide (I-124 NaI)6.2.4.3 Radioiodine I-125 Sodium Iodide (I-125 NaI); 6.2.4.4 Radioiodine I-131 Sodium Iodide (I-131 NaI); 6.2.4.5 Radioiodine I-123 Metaiodobenzylguanidine (I-123 MIBG); 6.2.4.6 Radioiodine I-131 Metaiodobenzylguanidine (I-131 MIBG); 6.2.5 Indium-111 Pentetreotide (In-111 Pentetreotide); 6.2.6 Radiopharmaceuticals with Techentium-99m; 6.2.6.1 Technetium-99m Pertechnetate (Tc-99m Pt); 6.2.6.2 Technetium-99m MIBI (Tc-99m MIBI or Sestamibi); 6.2.6.3 Technetium-99m Tetrofosmin (Tc-99m Tetrofosmin).
520	3		_aWith endocrinologists deploying nuclear medicine on a daily basis, and with the rapid development of the latter, this concise and up-to-date guide to the vital information required has been designed to maximize relevance and ease of use in clinical practice.
650		7	_2embne _aTiroides _xEnfermedades _9182475
650		7	_2embne _9140308 _aGlándulas endocrinas
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-56582-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI